The greatest threat from prescription drugs remains the FDA’s fast-track approval policy.
Originally conceived by advocates for critically ill patients, fast-track has become the tool of earnings-driven multinational drug corporations, who aggressively pursue the premature release of many medications, without adequate clinical trials and sufficient knowledge of how the drug will actually affect real-life patients.
Ultimately, the most vulnerable members of our society – children, the seriously ill, and the elderly – become unwitting guinea pigs for huge pharmaceutical corporations whose rush for immediate profits puts dangerous drugs on the market without sufficient knowledge or warnings of their dangers.